# Amivantamab (Genetical Recombination) / Vorhyaluronidase Alfa (Genetical Recombination) S.C. Injection (リブロファズ配合皮下注)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291503A1027). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291503A1027
- **Product name (Japanese):** リブロファズ配合皮下注
- **English title:** Amivantamab (Genetical Recombination) / Vorhyaluronidase Alfa (Genetical Recombination) S.C. Injection
- **Active ingredient:** アミバンタマブ（遺伝子組換え）・ボルヒアルロニダーゼ アルファ（遺伝子組換え）
- **Active ingredient (INN):** Amivantamab (Genetical Recombination) / Vorhyaluronidase Alfa (Genetical Recombination)
- **Strength / unit:** １０ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Janssen Pharmaceutical (ヤンセンファーマ)
- **NHI price (reference only):** JPY 480046 per １０ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291503A1027
- **JSON:** https://www.nifujipharma.com/api/drugs/4291503A1027

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Amivantamab%20(Genetical%20Recombination)%20%2F%20Vorhyaluronidase%20Alfa%20(Genetical%20Recombination)%20S.C.%20Injection%20(%E3%83%AA%E3%83%96%E3%83%AD%E3%83%95%E3%82%A1%E3%82%BA%E9%85%8D%E5%90%88%E7%9A%AE%E4%B8%8B%E6%B3%A8)%20%2F%20YJ%204291503A1027#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.